Leaflet AMPRIL 1.25mg tablets


Indicated for: hypertension

Substance: ramipril (ACE inhibitor)

ATC: C09AA05 (Cardiovascular system | Ace inhibitors, plain)

Ramipril is a medication used to treat high blood pressure, heart failure, and to reduce the risk of cardiovascular events such as heart attack or stroke. It belongs to the class of angiotensin-converting enzyme (ACE) inhibitors and works by relaxing blood vessels, which lowers blood pressure and reduces the workload on the heart.

Ramipril is also indicated for kidney protection in patients with diabetes or other conditions that may impair kidney function. It is taken orally, usually once daily, and the dosage is adjusted based on the patient's response and the condition being treated.

Common side effects include dizziness, dry cough, fatigue, headache, and nausea. Rarely, it may cause severe allergic reactions, angioedema (swelling of the face, lips, or throat), or kidney dysfunction. It is important to take ramipril as prescribed by a healthcare provider, and patients should avoid using potassium supplements or potassium-sparing diuretics to prevent hyperkalemia.

General data about AMPRIL 1.25mg

  • Substance: ramipril
  • Date of last drug list: 01-07-2013
  • Commercial code: W42969002
  • Concentration: 1.25mg
  • Pharmaceutical form: tablets
  • Quantity: 50
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: KRKA D.D. NOVO MESTO - SLOVENIA
  • Holder: KRKA D.D. NOVO MESTO - SLOVENIA
  • Number: 12116/2019/02
  • Shelf life: 2 years

Pharmaceutical forms available for ramipril

Concentrations available for ramipril

  • 1.25mg
  • 10mg
  • 2.5mg
  • 5mg
  • 7.5mg